IGF1 and Alzheimer disease: Several studies have reported a consistent reduction in insulin, IGF-1, and their receptors in postmortem brain tissue of AD patients, suggesting that insulin and IGF-1 resistance have an important pathophysiological role in the brain of patients with AD [75,76].